The global Proleukin market is estimated to grow at a significant CAGR during the forecast period. Proleukin is a medication that is used to treat kidney and skin cancers. This drug is the same as a body-produced natural substance (interleukin-2). This drug works in the body by affecting the body's natural defences (immune system). As a result of this effect, cancer cell proliferation is delayed or stopped.

According to the American Institute of Cancer Research, kidney cancer is the ninth most frequent cancer among males and the fourteenth most common cancer among females. In 2018, there were approximately 400,000 new cases of kidney cancer. Proleukin, also known as interleukin, is a kind of interleukin that is used to treat benign and malignant tumours in individuals with kidney cancer. Thus, the global Proleukin market will grow as the risk of kidney cancers rises as a result of changing lifestyles and an increasing geriatric population.

Proleukin is also employed as a therapy in the treatment of skin cancers due to excessive pollution and UV rays in the environment, there is a significant increase in skin cancers in adults. Proleukin's adoption as first-line therapy for skin cancer will propel the global Proleukin market forward. 

Some of the key players in the market include Novartis Inc., Chiron Corp., Prometheus Laboratories, Ironwood Pharmaceuticals, Takeda Pharmaceutical, among others. Prometheus Laboratories Inc., a speciality pharmaceutical and diagnostic company announced that it had inked a commercialization agreement with Novartis, providing it exclusive rights to market, advertise, and distribute PROLEUKIN (aldesleukin) in the US.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Type

o By Application

• Regions Covered

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape: Novartis Inc., Chiron Corp., Prometheus Laboratories, Ironwood Pharmaceuticals, Takeda Pharmaceutical.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Proleukin Market by Segments

By Type

• Injection
• Powder

By Application

• Hospital
• Pharmacies

Global Proleukin Market by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa